Overview

Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
0
Participant gender:
Female
Summary
The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Norton Healthcare
Treatments:
Contraceptive Agents
Etonogestrel
Norethindrone
Norethindrone Acetate
Criteria
Inclusion Criteria:

- Inclusion criteria will include any post---menarchal female presenting to the Kosair
Children's Hospital Gynecologic Specialist practice, who desires to use the
etonogestrel contraceptive implant and has access to a mobile phone device.

Exclusion Criteria:

- NA